Sanofi’s ambition to empower lives

Sanofi’s ambition to empower lives

Amid the continuous development of COVID-19 globally, French drugmaker Sanofi is seeking to fulfil its ambition of empowering people this year and beyond.
Popular pharma products withdrawn by multinationals

Popular pharma products withdrawn by multinationals

Multinationals like Sanofi, GSK, Adamed Pharma, and Merck Sharp & Dohme have requested marketing authorisation withdrawal of some pharmaceuticals, with it being unclear if the quality of some popular items is an underlying issue.
Digitalisation prompts evolution of healthcare

Digitalisation prompts evolution of healthcare

Burning to take advantage of Vietnam’s new digital transformation in the healthcare sector, international pharma giants like Novartis, AstraZeneca, Sanofi, and GSK are working to align with the new requirements and obtain sustainable gains.
Vaccine sales stir big pharma

Vaccine sales stir big pharma

Amidst lower-than-expected business performance, international pharma giants are betting on COVID-19 vaccine sales, hoping to alter the headwinds from the health crisis to their advantage.
Sanofi makes second run for EU-GMP recognition

Sanofi makes second run for EU-GMP recognition

Amid ongoing revision of the regulation of drug tenders at public hospitals, multinational corporations are renewing efforts to have EU-GMP standards for their manufacturing sites acknowledged in Vietnam to qualify for the most lucrative tenders.
Sanofi eyes approval of COVID-19 vaccine by first half of 2021

Sanofi eyes approval of COVID-19 vaccine by first half of 2021

PARIS: French drugmaker Sanofi said on Tuesday (Jun 23) it expects to get approval for the potential COVID-19 vaccine it is developing with Britain's GlaxoSmithKline by the first half of next year, faster than previously anticipated.
Pharma groups to profit from virus?

Pharma groups to profit from virus?

The top 10 global pharmaceutical companies are being scrutinised and advised not to prevent or delay a vaccine for COVID-19 from reaching vulnerable people to gain profits, triggering global concerns over their social responsibility.
Global virus vaccine race heats up, but not without controversy

Global virus vaccine race heats up, but not without controversy

Global tensions simmered over the race for a coronavirus vaccine on Thursday, as the United States and China traded jabs, and France slammed pharmaceuticals giant Sanofi for suggesting the US would get any eventual vaccine first.
Multinationals riding high in Vietnam’s pharma landscape

Multinationals riding high in Vietnam’s pharma landscape

Multinational corporations like Sanofi, GlaxoSmithKline, and Reckitt Benckiser gaining the advantage in Vietnam’s over-the-counter channel, or non-description drugs, in the first quarter of 2020 has in part fuelled their global performance.
Global pharma groups push on with operations

Global pharma groups push on with operations

Despite having risk management solutions to ensure drug import continuity to Vietnam in response to EU border closures, international pharma giants Sanofi, Zuellig Pharma, Adamed, and Novartis are closely monitoring the situation due to the potential direct impacts on long-term supply security.    
Drug price hikes in US threaten the same in Vietnam?

Drug price hikes in US threaten the same in Vietnam?

Pfizer, Sanofi, and GlaxoSmithKline are reported to plan increasing drug prices in the US in 2020, triggering public concerns over a similar hike in Vietnam.
Sanofi Vietnam celebrates first batch of pharmaceutical import

Sanofi Vietnam celebrates first batch of pharmaceutical import

Sanofi-Aventis Vietnam Ltd. has recently organised a ceremony to celebrate the first batch of pharmaceutical import in Ho Chi Minh City.
Vietnam’s six large-scale foreign pharmaceutical firms

Vietnam’s six large-scale foreign pharmaceutical firms 3

The massive entry of foreign pharmaceutical corporations, such as Sanofi, Taisho, and Abbott is creating considerable pressure for domestic pharmaceutical enterprises.